Skip to main content

Table 3 Follow up assessment of the 37 children after long term treatment

From: Prognosis and treatment of 46 Chinese pediatric cystic fibrosis patients

Variables N = 37
Follow up duration -year 2.88 ± 1.72 (0.03–9.21, median 2.83)
Age at follow up 10.63 ± 5.23 (2.45–20.04, median 11.16)
Pancreatic malfunction -no/total no (%) 15/37 (40.54)
BMI 16.87 ± 3.54
BMI centiles 32.26% ± 32.75% (0.1–98.5%, 18.9%)
BMI Z-score −0.78 ± 1.46
Acute exacerbation times 1.62 ± 1.71
Respiratory infection times after treatment 1.97 ± 1.87
Lung function -no/total no (%) 17/37 (45.95)
 FEV1 75.26% ± 22.34% (34.8–120.2%, 80%)
 FVC 86.99% ± 19.95% (41.4–116.5%, 92%)
 FEF75 36.63% ± 24.30% (7–99.2%, 30.3%)
 Change of lung function –no/total no (%) 17/37 (45.95)
 Better -no/total no (%) 7/17 (41.18)
 Worse -no/total no (%) 10/17 (58.82)
Bacterial colonies -no/total no (%) 27/37 (72.97)
 PA -no/total no (%) 17/27 (62.96)
 SA -no/total no (%) 6/27 (22.22)
Changes of bronchiectasis -no/total no (%) 22/37 (59.46)
 Decrease -no/total no (%) 3/22 (13.64)
 Unchanged -no/total no (%) 13/22 (59.09)
 Increase -no/total no (%) 6/22 (27.27)
  1. Plus–minus values are means ±SD